Featured Research

from universities, journals, and other organizations

Researchers earn patent of use for anti-obesity compound

Date:
December 16, 2013
Source:
Skidmore College
Summary:
Two researchers have been awarded U.S. Patent No. 8,598,150 for use of an antioxidant compound that shows promise in the treatment of obesity and related disorders, such as type-2 diabetes.

A Skidmore College alumnus and professor have been awarded U.S. Patent No. 8,598,150 for use of an antioxidant compound that shows promise in the treatment of obesity and related disorders, such as type-2 diabetes.

Related Articles


The researchers -- Jonathan R. Brestoff Parker, a 2008 Skidmore graduate and currently a trustee of the college, and Thomas H. Reynolds, associate professor of health and exercise sciences -- discovered that treating obese mice with an antioxidant called MnTBAP decreases obesity and improves type-2 diabetes.

Obese mice that received the compound lost 40 percent of their body weight. "To put that number in context, if a 300-pound obese person lost 40 percent of their body weight, they would have lost 120 pounds," said Brestoff Parker.

The compound works by breaking down triglycerides, which are stored in excess in fat tissue of obese people. The researchers' next step, according to Reynolds, is "to figure out how that happens. What are the cellular and molecular events that result in weight loss?" He calls this stage of drug development "the fun part of science -- trying to design the next study that will yield information about how a biological system responds to a drug."

The original research showing that MnTBAP dramatically decreases obesity was Brestoff Parker's senior thesis. A personal challenge motivated his interest. He explained, "I struggled with being overweight throughout my childhood and adolescence. A lot of people know what that struggle feels like and how challenging and frustrating it is to shed pounds. That challenge and frustration inspired me to study the molecular basis of obesity with the hope of being able to use that knowledge in an empowering way."

Brestoff Parker and Reynolds continue to collaborate. The Reynolds laboratory is further investigating how antioxidant compounds such as MnTBAP promote weight loss. Brestoff Parker, now working toward M.D. and Ph.D. degrees at the University of Pennsylvania Perelman School of Medicine, is investigating in unrelated studies how the immune system regulates the development of obesity. Together, they aim to publish their work and progress through the drug development process.


Story Source:

The above story is based on materials provided by Skidmore College. Note: Materials may be edited for content and length.


Cite This Page:

Skidmore College. "Researchers earn patent of use for anti-obesity compound." ScienceDaily. ScienceDaily, 16 December 2013. <www.sciencedaily.com/releases/2013/12/131216183654.htm>.
Skidmore College. (2013, December 16). Researchers earn patent of use for anti-obesity compound. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2013/12/131216183654.htm
Skidmore College. "Researchers earn patent of use for anti-obesity compound." ScienceDaily. www.sciencedaily.com/releases/2013/12/131216183654.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins